GlassScriptPhysician profile
Thomas M Chengot
NPI 1295960094
$34,489.65
in general payments reported to CMS, 2019-2025
61 companies · $4,668 in 2025
The $4,668 reported for 2025 was more than what 82% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,507 · 2020: $3,473 · 2021: $5,639 · 2022: $4,316 · 2023: $5,337 · 2024: $3,551 · 2025: $4,668.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $1,701 · Education: $269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,585.10 |
| Travel and Lodging | $1,701.04 |
| Education | $268.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,488.58 | 2019-2025 | Dragonfly Opstar, Optis, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic Vascular, INC. | $4,684.11 | 2019-2020 | |
| Medtronic, INC. | $4,082.46 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Linq II |
| Inari Medical, INC. | $1,974.31 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Edwards Lifesciences Corporation | $1,677.79 | 2019-2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $1,568.59 | 2019-2023 | Xarelto |
| Abiomed | $1,385.32 | 2021-2025 | Impella |
| Medical Device Business Services, INC. | $1,181.63 | 2019 | |
| Novartis Pharmaceuticals Corporation | $981.56 | 2019-2025 | |
| Boston Scientific Corporation | $979.45 | 2019-2025 | Watchman Flx, Avvigo Guidance System, Rotapro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $960.05 | 2019-2024 | Jardiance |
| Actelion Pharmaceuticals US, INC. | $862.88 | 2019-2025 | Opsumit, Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $687.60 | 2019-2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $686.05 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Amgen INC. | $647.55 | 2019-2025 | Repatha, Repatha |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $637.30 | 2024-2025 | Barostim Neo System |
| Novo Nordisk INC | $545.77 | 2019-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $498.27 | 2019-2025 | |
| Medicomp INC | $468.83 | 2022-2025 | Telepatch Cardiac Monitor |
| E.R. Squibb & Sons, L.L.C. | $451.23 | 2019-2025 | Camzyos, Eliquis |
| Amarin Pharma, INC. | $398.86 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $357.50 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $302.72 | 2019-2023 | |
| Esperion Therapeutics, INC. | $262.83 | 2020-2024 | Nexletol |
| Daiichi Sankyo INC. | $259.19 | 2022-2024 | Injectafer |
| Penumbra, INC. | $192.98 | 2024-2025 | Indigo System |
| Chiesi USA, INC. | $182.16 | 2020-2022 | |
| Arbor Pharmaceuticals, INC. | $161.85 | 2019-2021 | |
| Intra-Sana Laboratories | $146.85 | 2024 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Shockwave Medical, INC | $142.31 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Octapharma USA, INC. | $124.96 | 2025 | Balfaxar |
| Kiniksa Pharmaceuticals, LTD. | $123.12 | 2023 | Arcalyst |
| Merck Sharp & Dohme LLC | $117.60 | 2022-2025 | Verquvo |
| Regeneron Healthcare Solutions, INC. | $113.89 | 2019-2023 | Evkeeza |
| Lundbeck LLC | $108.51 | 2019-2020 | |
| Tactile Systems Technology INC | $106.15 | 2024-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| Alnylam Pharmaceuticals INC. | $89.97 | 2025 | Amvuttra |
| Bardy Diagnostics, INC. | $82.17 | 2020-2022 | |
| Stryker Corporation | $73.41 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kowa Pharmaceuticals America, INC. | $72.58 | 2021-2023 | Livalo |
| Irhythm Technologies, INC. | $70.93 | 2023 | Zio Xt Patch |
| Philips North America LLC | $62.13 | 2025 | Mcot |
| Heartflow, INC. | $56.91 | 2022-2024 | Ffrct |
| Scpharmaceuticals INC. | $45.38 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $38.04 | 2024 | Arcalyst |
| Cardiovascular Systems INC. | $28.86 | 2019 | |
| Cardiva Medical, INC. | $28.72 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Baxter Healthcare | $27.89 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Kestra Medical Technology Services, INC. | $24.40 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $23.80 | 2023 | Inpefa |
| Terumo Medical Corporation | $23.53 | 2023 | Angio-Seal |
| 180 Medical, INC. | $22.95 | 2024 | Medi |
| Bridgebio Pharma, INC. | $22.64 | 2025 | Attruby |
| Ionis Pharmaceuticals, INC. | $21.84 | 2025 | Tryngolza |
| Acorda Therapeutics, INC | $20.55 | 2024 | Inbrija |
| W. L. Gore & Associates, INC. | $19.87 | 2025 | Gore Cardioform Septal Occluder |
| Glaxosmithkline, LLC. | $19.30 | 2025 | Shingrix, Arexvy |
| Althera Pharmaceuticals LLC | $19.29 | 2021 | |
| Infobionic, INC | $15.55 | 2019 | |
| Dexcom, INC. | $15.04 | 2024 | Dexcom G6 Transmitter |
| Gilead Sciences, INC. | $13.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Chengot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.